# Guilin China Resources Tianhe Pharmaceutical Co., Ltd. – FDA Inspection, Jan 11, 2019

Source: https://www.keypedia.com/records/fda_inspections/guilin-china-resources-tianhe-pharmaceutical-co-ltd/497581b2-9e0b-4df5-9e17-370621d1acb6
Source feed: FDA_Inspections

> FDA inspection 1078047 of Guilin China Resources Tianhe Pharmaceutical Co., Ltd., January 11, 2019. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1078047
- Company Name: Guilin China Resources Tianhe Pharmaceutical Co., Ltd.
- Inspection Date: 2019-01-11
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- [FDA Inspection 1268372 - 2025-03-28](https://www.keypedia.com/records/fda_inspections/guilin-china-resources-tianhe-pharmaceutical-co-ltd/8e55f59b-b213-4c68-9f30-c9810bec4d5e)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/camerson-e-moore/50733244-0d55-4b0b-a758-f192b7c66457)

Company: https://www.keypedia.com/companies/guilin-china-resources-tianhe-pharmaceutical-co-ltd/a267013f-a39d-4270-a42a-8ba4706e6b86

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c